Latest News about ALNY
Recent news which mentions ALNY
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
From Benzinga
Should You Buy Sage Stock After the Biogen Investment?
December 19, 2020
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
December 18, 2020
From Motley Fool
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
From Benzinga
Is The FDA Still Approving Drugs During the Pandemic?
December 04, 2020
From Motley Fool
Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
From Benzinga
Why These 3 Pharma Stocks Are Moving Today
November 24, 2020
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
12 Healthcare Stocks Moving In Thursday's After-Market Session
October 22, 2020
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
From Benzinga
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
October 18, 2020
From Benzinga
9 Biotech Stocks With Material Catalysts In Q4
October 13, 2020
From Benzinga
5 Reasons I Bought More Slack After Its Seemingly Disappointing Quarter
September 29, 2020
From Motley Fool
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
September 26, 2020
From Benzinga
Better Coronavirus Stock: BioNTech or Vir Biotechnology?
September 26, 2020
From Motley Fool
3 Healthcare Stocks I Can't Wait to Buy When the Stock Market Tanks Again
September 09, 2020
From Motley Fool
Should You Invest in Coronavirus ETFs?
September 06, 2020
From Motley Fool
The Daily Biotech Pulse: Moderna Japanese Vaccine Deal Talk, Lipocine FDA Decision, Liver Congress Presentations
August 28, 2020
From Benzinga
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
August 23, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 12, 2020
August 12, 2020
From Benzinga
Tickers
ALNY
From Motley Fool
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
August 06, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.